Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

IMMUCELL CORP /DE/ (ICCC) Stock Forecast 2025 - AI Price Prediction & Analysis

IMMUCELL CORP /DE/ (ICCC) AI Stock Price Forecast & Investment Analysis

IMMUCELL CORP /DE/ Stock Price Chart and Technical Analysis

Loading IMMUCELL CORP /DE/ interactive price chart and technical analysis...

IMMUCELL CORP /DE/ (ICCC) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

IMMUCELL CORP /DE/ (Stock Symbol: ICCC) is a leading company in the Life Sciences sector , specifically operating within the In Vitro & In Vivo Diagnostic Substances industry. The organization employs approximately 43 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.

Financial Performance & Key Metrics Analysis

Annual Revenue: $26 million generating a -15.3% net profit margin .

Market Capitalization: $55 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 3.6% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for IMMUCELL CORP /DE/ stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

IMMUCELL CORP /DE/ strategically competes in the highly dynamic In Vitro & In Vivo Diagnostic Substances marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . , complemented by impressive 463.4% year-over-year cash flow growth. The company maintains a healthy 22.8% gross margin, indicating strong pricing power and operational efficiency.

IMMUCELL CORP /DE/ (ICCC) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for IMMUCELL CORP /DE/ stock analysis.

Loading IMMUCELL CORP /DE/ comprehensive fundamental analysis and insider trading data...

Deep dive into IMMUCELL CORP /DE/'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if IMMUCELL CORP /DE/ stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For IMMUCELL CORP /DE/: With a P/E ratio of 31.27, the market highly values future growth prospects.

P/E Ratio 31.27x
P/B Ratio 1.84x
Market Cap $55M
Dividend Yield 9.96%
EPS $0.21
Book Value/Share $3.30
Revenue/Share $2.96
FCF/Share $-0.47
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently IMMUCELL CORP /DE/ converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For IMMUCELL CORP /DE/: An ROE of 3.6% indicates room for improvement in shareholder value creation.

ROE 3.6%
ROA 2.6%
ROIC 3.3%
Gross Margin 22.8%
Operating Margin -14.6%
Net Margin -15.3%
EBT Margin 5.3%
Tax Rate 0.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess IMMUCELL CORP /DE/'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For IMMUCELL CORP /DE/: A current ratio of 7.78 indicates strong liquidity.

Current Ratio 7.78x
Quick Ratio 6.16x
D/E Ratio 0.33x
Financial Leverage 1.40x
Interest Coverage 4.6x
Working Capital $10M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal IMMUCELL CORP /DE/'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For IMMUCELL CORP /DE/: Free cash flow of $-1M indicates cash challenges that need attention.

Operating Cash Flow $2M
Free Cash Flow $-1M
Capital Spending $-3M
OCF Growth YoY 463.4%
FCF Growth YoY 626.1%
FCF/Sales -4.0%
CapEx/Sales 14.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively IMMUCELL CORP /DE/ uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For IMMUCELL CORP /DE/: An asset turnover of 0.49x suggests room for improvement in asset utilization.

Asset Turnover 0.49x
Receivables Turnover 8.4x
Inventory Turnover 4.0x
Fixed Assets Turnover 0.8x
Days Sales Outstanding 44 days
Days Inventory 92 days
Payables Period 23 days
Cash Conversion Cycle 113 days
Understanding Financial Statement Data

What these metrics mean: Key figures from IMMUCELL CORP /DE/'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For IMMUCELL CORP /DE/: With annual revenue of $26M, IMMUCELL CORP /DE/ represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $26M
R&D Expense $4M
SG&A Expense $22M
Cost of Goods Sold $17M
Balance Sheet Highlights ($ Millions)
Total Current Assets $39M
Cash & Short-term Investments $25M
Total Liabilities $29M
Short-term Debt $2M
Accounts Receivable $6M
Inventory $7M
Dividend & Shareholder Information
Dividends Per Share $0.90
Payout Ratio 130.4%
Shares Outstanding 9M
Growth Metrics (YoY)
EPS Growth -10.0%

Latest IMMUCELL CORP /DE/ Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting IMMUCELL CORP /DE/ (ICCC) stock price and investment outlook.

IMMUCELL CORP /DE/ Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of IMMUCELL CORP /DE/ against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACHV Unlock Forecast $145M -3.7x 3.5x
AWH Unlock Forecast $2M -0.5x -0.7x
AWHL Unlock Forecast $15M x x
BMRA Unlock Forecast $5M -0.8x 0.9x
BZYR Unlock Forecast $5M x x
CDIO Unlock Forecast $6M -2.3x 0.6x
CDIOW Unlock Forecast $2M x 0.5x
CLDX Unlock Forecast $1477M -10.1x 2.3x
ICCC Unlock Forecast $55M 31.3x 1.8x
IDXX Unlock Forecast $52710M 53.5x 36.1x
IMDX Unlock Forecast $82M x 8.0x
LNTH Unlock Forecast $4076M 15.0x 3.5x
MYGN Unlock Forecast $560M -8.6x 1.4x
NEOG Unlock Forecast $1211M -145.7x 0.5x
NTLA Unlock Forecast $1225M -2.6x 1.6x
OCX Unlock Forecast $81M -0.7x 7.9x
QDEL Unlock Forecast $1882M -1.6x 0.7x
TKNO Unlock Forecast $254M -8.6x 3.3x
TNFA Unlock Forecast $1M -0.2x 0.1x
VNRX Unlock Forecast $75M 2.7x -2.5x

Frequently Asked Questions - IMMUCELL CORP /DE/ Stock Forecast

How accurate are IMMUCELL CORP /DE/ stock predictions?

Our AI model demonstrates 42% historical accuracy for ICCC predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence IMMUCELL CORP /DE/ stock price forecasts?

Our analysis considers IMMUCELL CORP /DE/'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is IMMUCELL CORP /DE/ a good investment in 2025?

Based on our AI analysis, IMMUCELL CORP /DE/ shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are IMMUCELL CORP /DE/ forecasts updated?

IMMUCELL CORP /DE/ stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced IMMUCELL CORP /DE/ Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for IMMUCELL CORP /DE/ stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...